Antibody-Free Rapid Detection of SARS-CoV-2 Proteins Using Corona Phase Molecular Recognition (CoPhMoRe)
Invention type: Technology
/
Case number: #23605
Corona phase molecular recognition (CoPhMoRe) that enables the molecular recognition of SARS-CoV-2 viral proteins without the need for antibody or enzymatic receptor incorporation.
Researchers
Michael S. Strano
/
Jianqiao Leslie Cui
/
Sungyun Yang
/
Xiaojia Jin
/
Sooyeon Cho
/
Xun Gong
Departments: Department of Chemical Engineering, Chemical Engineering
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials, Polymers / Diagnostics: Assays / Sensing & Imaging: Optical Sensing
Impact Areas: Healthy Living
-
antibody-free rapid detection of sars-cov-2 proteins using coronaphase molecular recognition (cophmore)
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.